Johnson & Johnson vs Mettler-Toledo International, I — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
6.9
Neutral
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
MTD
Earnings growing 17% year-over-year on 8% revenue growth.
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
HOLD
Target $1488.31 (+17.5%)
13 analysts
Fundamentals
JNJ
MTD
26.3×
Trailing P/E
30.1×
17.9×
Forward P/E
24.7×
21.8%
Profit Margin
21.6%
68.0%
Gross Margin
59.4%
26.4%
ROE
—
9.9%
Revenue Growth
8.1%
-52.9%
Earnings Growth
17.0%
0.33
Beta
1.44
—
Price / Book
—
$546.9B
Market Cap
$25.7B
$146 – $252
52-Week Range
$1,052 – $1,525
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →